Skip to main content

3 Result(s)

within Nadia Trivieri Remove this filter Apoptosis Remove this filter

and

  1. Article

    Open Access

    Different states of stemness of glioblastoma stem cells sustain glioblastoma subtypes indicating novel clinical biomarkers and high-efficacy customized therapies

    Glioblastoma (GBM) is the most malignant among gliomas with an inevitable lethal outcome. The elucidation of the physiology and regulation of this tumor is mandatory to unravel novel target and effective thera...

    Alberto Visioli, Nadia Trivieri… in Journal of Experimental & Clinical Cancer … (2023)

    Download PDF (4696 KB) View Article

  2. Article

    Open Access

    Growth factor independence underpins a paroxysmal, aggressive Wnt5aHigh/EphA2Low phenotype in glioblastoma stem cells, conducive to experimental combinatorial therapy

    Glioblastoma multiforme (GBM) is an incurable tumor, with a median survival rate of only 14–15 months. Along with heterogeneity and unregulated growth, a central matter in dealing with GBMs is cell invasivenes...

    Nadia Trivieri, Alberto Visioli… in Journal of Experimental & Clinical Cancer … (2022)

    Download PDF (11461 KB) View Article

  3. Article

    Open Access

    BRAFV600E mutation im**es on gut microbial markers defining novel biomarkers for serrated colorectal cancer effective therapies

    Colorectal cancer (CRC) harboring BRAFV600E mutation exhibits low response to conventional therapy and poorest prognosis. Due to the emerging correlation between gut microbiota and CRC carcinogenesis, we investig...

    Nadia Trivieri, Riccardo Pracella… in Journal of Experimental & Clinical Cancer … (2020)

    Download PDF (3496 KB) View Article